The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis

TTA provided prompt, effective, and safe reduction of platelet count in the treatment of extreme thrombocytosis.

Authors

Institutions

Publication Details

Journal
Transfusion Medicine
Published
2025-05-19
DOI
https://doi.org/10.1111/tme.13150
Citations
2
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
3.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis

Leylagül Kaynar, Ali Ünal, Serhat Çelik, Muzaffer Keklık et al.
2 citations
Transfusion Medicine
Myeloproliferative Neoplasms: Diagnosis and Treatment
3.25
article

The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis

Leylagül Kaynar, Ali Ünal, Serhat Çelik, Muzaffer Keklık, Zeynep Tuğba Güven
article en
2 citations

Abstract

TTA provided prompt, effective, and safe reduction of platelet count in the treatment of extreme thrombocytosis.

Transfusion MedicineVol. 35(3)
Ministry of Health (TR), Istanbul Medipol University (TR), Erciyes University (TR)
Good health and well-being
Openalex Percentile: Top 9%
Myeloproliferative Neoplasms: Diagnosis and Treatment
3.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.